Incretin-based therapy in combination with basal insulin: A promising tactic for the treatment of type 2 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incretin-based therapy in combination with basal insulin: A promising tactic for the treatment of type 2 diabetes

Published:2013-02 Issue:1 Volume:39 Page:6-15
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Vora J.,Bain S.C.,Damci T.,Dzida G.,Hollander P.,Meneghini L.F.,Ross S.A.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference73 articles.

1. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetologia,2009

2. Metformin as first choice in oral diabetes treatment: the UKPDS experience;Holman;J Annu Diabetol Hotel Dieu,2007

3. Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin-based therapies;Ban;J Am Soc Hypertens,2009

4. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus;Hermansen;Drug Saf,2007

5. Type 2 diabetes mellitus and heart failure;Choy;Pharmacotherapy,2008

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KCNQ1 variant rs163184 is a potential biomarker of glycemic response to exenatide;Pharmacogenomics;2022-04

2. Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes;Drugs;2020-01-20

3. Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes;Metabolism;2019-10

4. IDegLira improves patient‐reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy;Diabetes, Obesity and Metabolism;2019-08-28

5. APPROACHES TO INSULIN USE;ENDOCR PRACT;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3